GE Healthcare Korea said it has entered a strategic partnership with SK Telecom to build digital healthcare infrastructure in Korea.Through this partnership, the two companies will cooperate in exchanging and operating related technologies to realize digital healthcare solutions and the commercializ
Hanall Biopharma has begun administrating HL161 (ingredient: batoclimab) in phase 3 clinical trials conducted in China for treating myasthenia gravis. Harbour Biomed, Hanall Biopharm’s Chinese partner, is conducting clinical trials in patients with a rare long-term condition that causes muscle weakn
A research team at Severance Hospital has developed a cell membrane-derived nanoparticle (CMNP) capable of preserving the larynx in laryngeal cancer.The hospital said that intercellular interactions help cell growth, differentiation, and tissue regeneration and affect cancer development and metastas
Korea Health Industry Development Institute (KHIDI) and the Korean Embassy in Washington will host a seminar to help domestic companies advance to Boston Biocluster at Cambridge Marriott Hotel, Boston, next Friday. The workshop will be held by the Ministry of Health and Welfare’s Medical Korea base
A Seoul National University Bundang Hospital (SNUBH) research team has developed an algorithm that can predict acute kidney injury in patients who have received kidney cancer surgery.Acute kidney injury is a disease in which renal function weakens due to sudden damage to the kidney cells. If not tre
About 27 percent of local epilepsy patients have drug-resistant epilepsy (DRE), and the nation needs to actively introduce new anti-epileptic drugs (AEDs) to treat them effectively, neurologists said. DRE refers to a condition when two AEDs have failed to control seizures.Korean Epilepsy Society’s (
Second-generation renal denervation (RDN), using high-frequency sound waves, can lower blood pressure significantly and consistently with excellent safety in patients with intractable hypertension that is difficult to treat with antihypertensive drugs, local researchers said in a study.RDN could be
Local developers of Covid-19 vaccines have announced plans to conduct large-scale, late-stage global trials, raising expectations for homegrown Covid-19 vaccines.However, some companies have to overcome several challenges, and it will take some time to commercialize a local Covid-19 vaccine, observe
Daewon Pharmaceutical said that it found TG Fenon (Ingredient: fenofibrate choline) significantly reduces triglyceride levels, reaffirming its safety in phase 4 clinical trial of treating patients with hypertriglyceridemia.The company compared triglyceride reduction between patient groups that recei
Korea University Anam Hospital (KUAH) said its neurosurgery team is drawing the attention of academia with the study results of regenerative therapies, including the finding of new mediators for the stem cell therapy of ischemic stroke.The research team, led by Professor Park Dong-hyuk, has made sig
The government said that it would provide booster shots for those vulnerable to the Covid-19 virus from next month to increase the inoculation effect of the vaccine and deal with the more contagious Delta variant.A booster shot refers to receiving an additional vaccine jab after a certain point in t
Novartis’ CDK4/6 inhibitor Kisqali (ribociclib), combined with letrozole, extended overall survival by more than one year in patients with hormone receptor-positive, human epidermal growth factor 2-negative (HR+/HER2-) advanced breast cancer.The company released the results of phase 3 MONALEESA-2 tr
Asan Medical Center (AMC) has been included in the top 50 global hospitals in eight of the 10 specialized treatments, according to Newsweek.The U.S. weekly news magazine rates each hospital through an online survey conducted by Statista, a German market surveyor and consumer data agency, on tens of
The number of patients treated for heart diseases caused by myocardial ischemia sharply grew in Korea over the past five years, significantly increasing medical expenses for their treatment, data showed.According to the National Health Insurance Service, the number of patients with ischemic heart di
Covid-19 patients felt the need for home treatment more than the general public, and nearly half of the patients thought they did not receive good treatment, a survey found.The National Medical Center conducted a public perception survey to establish a response strategy to the prolonged Covid-19 pan
Samsung Medical Center (SMC) said Monday that it has confirmed the efficacy of a combination of cytotoxic chemotherapy and Keytruda (ingredient: pembrolizumab) for esophagus cancer in the global phase 3 clinical trials.The global study, led by Professor Sun Jong-mu of the Department of Hematology an
The Seoul National University Bundang Hospital (SNUBH) said Monday that its researchers have discovered that antidepressants may relieve chronic dizziness.“Most dizziness appears as a temporary symptom, and patients often ignore the symptoms because it subsides,” the hospital said. “However, if the
JW Creagene said Monday that it would cooperate with Oncoinsight to develop the next-generation anticancer cell therapy called CAR-M.Through this collaboration, the two companies will jointly research and develop a CAR-Macrophage (CAR-M). This anticancer cell therapy combines a chimeric antigen rece
The market competition of combination therapies for hypertension and dyslipidemia is likely to heat up, as Yuhan Corp. and JW Pharmaceutical recently won approval for related products.Prescriptions of dyslipidemia combo drugs jumped 21 percent on-year to 633.5 billion won ($536.7 million) in Korea i
Avastin (bevacizumab), a vascular endothelial growth factor (VEGF) inhibitor, is almost a staple in anticancer treatment combined with chemotherapy or immunotherapy in various types of cancer.After Samsung Bioepis’ biosimilar of Avastin became reimbursable in Korea, the government notified that it w